The Brookhill Pharmaceutical New York City, NY - 10022

The Brookhill Pharmaceutical is categorized under Health Care Management in New York City, NY and active since 1999.

The Brookhill Pharmaceutical was established in 1999, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Health Care Management business, which does work in the B2B market, and is classified as a Health Care Management, under code number 541611 by the NAICS.

If you are seeking more information, feel free to contact Ronald B Bruder at the company’s single location by writing to 501 Madison Avenue Floor 18, New York City, New York NY 10022 or by phoning (212) 753-3123. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: The Brookhill Pharmaceutical
Contact Person: Ronald B Bruder
Address: 501 Madison Avenue Floor 18, New York City, New York 10022
Phone Number: (212) 753-3123
Annual Revenue (USD): $100.000 to $499.999
Founded: 1999
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Health Care Management
SIC Code: 8742
NAICS Code: 541611
Share This Business:

The Brookhill Pharmaceutical was started in 1999 to provide professional Health Care Management under the SIC code 8742 and NAICS code 541611. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.

Feel free to contact Ronald B Bruder for inquiries that concern The Brookhill Pharmaceutical by calling the company number (212) 753-3123, as your correspondence is most welcome. Additionally, the physical location of the single location of The Brookhill Pharmaceutical can be found at the coordinates 40.759155,-73.974434 as well as the street address 501 Madison Avenue Floor 18 in New York City, New York 10022.

For its online presence, you may visit The Brookhill Pharmaceutical’s website at and engage with its social media outlets through on Twitter and on Facebook.